Former President Trump plans to impose hefty import taxes, potentially up to 200%, on pharmaceuticals, a sector previously largely exempt from tariffs. While aiming to lower drug costs and bolster domestic manufacturing, experts warn these tariffs could lead to significantly higher prices for consumers, especially for generic drugs, and create supply shortages. The policy, which might include delays for companies to stockpile or relocate production, also seeks to address national security concerns regarding reliance on foreign drug supply chains. However, analysts caution that even lower tariffs could substantially raise U.S. drug prices and disrupt the complex, globalized pharmaceutical supply network.

Source: WEAU